{"id":50917,"date":"2025-04-15T16:49:58","date_gmt":"2025-04-15T07:49:58","guid":{"rendered":"https:\/\/www.veeva.com\/jp\/?post_type=resources&#038;p=50917"},"modified":"2025-04-15T17:00:41","modified_gmt":"2025-04-15T08:00:41","slug":"five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/","title":{"rendered":"\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u304b\u3089\u306e\u8131\u5374\uff1a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304a\u3088\u3073 CRO 5 \u793e\u306b\u304a\u3051\u308b\u6700\u65b0 EDC \u306e\u6d3b\u7528\u4e8b\u4f8b"},"content":{"rendered":"<style>blockquote strong { font-size: 115%; } blockquote cite { font-weight: bold; }<\/style>\n<p>\u5f93\u6765\u306e\u96fb\u5b50\u30c7\u30fc\u30bf\u53ce\u96c6\uff08EDC\uff09\u30b7\u30b9\u30c6\u30e0\u306b\u306f\u3001\u4eca\u65e5\u306e\u81e8\u5e8a\u8a66\u9a13\u3067\u8981\u6c42\u3055\u308c\u308b\u8907\u96d1\u306a\u30d7\u30ed\u30c8\u30b3\u30eb\u3084\u983b\u7e41\u306a\u4fee\u6b63\u306b\u5bfe\u5fdc\u3059\u308b\u306b\u306f\u67d4\u8edf\u6027\u304c\u6b20\u3051\u3066\u3044\u307e\u3059\u3002\u305d\u3046\u3057\u305f\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u306f\u3001\u96a0\u308c\u305f\u30c7\u30fc\u30bf\u7ba1\u7406\u554f\u984c\u3092\u751f\u307f\u51fa\u3059\u3053\u3068\u3067\u81e8\u5e8a\u8a66\u9a13\u30c1\u30fc\u30e0\u306e\u696d\u52d9\u3092\u59a8\u3052\u3001\u81e8\u5e8a\u80fd\u529b\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u307e\u3059\u3002\u30ec\u30ac\u30b7\u30fc\u30b7\u30b9\u30c6\u30e0\u3092\u4f7f\u7528\u3059\u308b\u30c7\u30fc\u30bf\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u306f\u3001\u624b\u4f5c\u696d\u306b\u3088\u308b\u8fc2\u56de\u63aa\u7f6e\uff08\u30ef\u30fc\u30af\u30a2\u30e9\u30a6\u30f3\u30c9\uff09\u3092\u8b1b\u3058\u305f\u308a\u3001\u30ab\u30b9\u30bf\u30e0\u30d7\u30ed\u30b0\u30e9\u30df\u30f3\u30b0\u3092\u884c\u3063\u305f\u308a\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u3001\u305d\u308c\u306b\u3088\u3063\u3066\u30dc\u30c8\u30eb\u30cd\u30c3\u30af\u304c\u751f\u3058\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u719f\u7df4\u3057\u305f\u30ea\u30bd\u30fc\u30b9\u306e\u5727\u8feb\u3001\u81e8\u5e8a\u77e5\u898b\u306e\u9045\u308c\u3001\u30b9\u30bf\u30c7\u30a3\u30b3\u30b9\u30c8\u306e\u5897\u52a0\u306b\u3064\u306a\u304c\u308a\u307e\u3059\u3002<\/p>\n<p>\u30c7\u30fc\u30bf\u7ba1\u7406\u696d\u52d9\u3092\u793e\u5185\u3067\u79fb\u884c\u3059\u308b\u306b\u305b\u3088\u3001\u533b\u85ac\u54c1\u958b\u767a\u696d\u52d9\u53d7\u8a17\u6a5f\u95a2\uff08CRO\uff09\u30d1\u30fc\u30c8\u30ca\u30fc\u306b\u5225\u30b7\u30b9\u30c6\u30e0\u3078\u306e\u79fb\u884c\u3092\u4f9d\u983c\u3059\u308b\u306b\u305b\u3088\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u306f\u81e8\u5e8a\u30c7\u30fc\u30bf\u3092\u3088\u308a\u7ba1\u7406\u3057\u3084\u3059\u304f\u3059\u308b\u65b9\u6cd5\u3092\u6a21\u7d22\u3057\u3066\u3044\u307e\u3059\u3002\u591a\u304f\u306e\u30e6\u30fc\u30b6\u30fc\u304c\u30ec\u30ac\u30b7\u30fc\u30d9\u30f3\u30c0\u30fc\u306b\u3088\u308b\u79fb\u884c\u307e\u305f\u306f\u30a2\u30c3\u30d7\u30b0\u30ec\u30fc\u30c9\u306e\u5fc5\u8981\u306b\u8feb\u3089\u308c\u308b\u4e2d\u3001\u6700\u65b0\u306e\u30a2\u30b8\u30e3\u30a4\u30ebEDC\u30b7\u30b9\u30c6\u30e0\u306b\u5207\u308a\u66ff\u3048\u308b\u6642\u671f\u304c\u6765\u3066\u3044\u307e\u3059\u3002<\/p>\n<div style=\"text-align: center;\"><img decoding=\"async\" style=\"margin: 1em auto; width: 100%; max-width: 400px; height: auto;\" src=\"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/03\/article-fig1.png\" alt=\"\"><\/div>\n<h3>\u81e8\u5e8a\u8a66\u9a13\u74b0\u5883\u5168\u4f53\u306b\u308f\u305f\u308b\u6a19\u6e96\u5316<\/h3>\n<p>\u30c7\u30fc\u30bf\u306e\u6240\u6709\u6a29\u3092\u518d\u53d6\u5f97\u3059\u308b\u65b9\u6cd5\u306f\u6570\u591a\u304f\u3042\u308a\u307e\u3059\u304c\u3001\u5171\u901a\u3059\u308b\u6210\u529f\u8981\u56e0\u306f\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u30e2\u30c7\u30eb\u306e\u6a19\u6e96\u5316\u3067\u3059\u3002<\/p>\n<p>\u30b9\u30a4\u30b9\u306b\u672c\u793e\u3092\u7f6e\u304f\u4e2d\u5805\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u3067\u3042\u308bIdorsia Pharmaceuticals\u793e\u306f\u3001\u4ee5\u524d\u306f\u3059\u3079\u3066\u306e\u81e8\u5e8a\u8a66\u9a13\u3092\u5916\u90e8\u59d4\u8a17\u3057\u3066\u3044\u307e\u3057\u305f\u3002\u30c1\u30fc\u30e0\u306f\u81e8\u5e8a\u8a66\u9a13\u4ed5\u69d8\u66f8\u3092CRO\u30d1\u30fc\u30c8\u30ca\u30fc\u306b\u9001\u308a\u3001\u4ed5\u69d8\u66f8\u3092\u53d7\u3051\u53d6\u3063\u305fCRO\u30d1\u30fc\u30c8\u30ca\u30fc\u306f\u30b7\u30b9\u30c6\u30e0\u3067\u306e\u30b9\u30bf\u30c7\u30a3\u306e\u69cb\u7bc9\u3001\u30e6\u30fc\u30b6\u30fc\u53d7\u3051\u5165\u308c\u30c6\u30b9\u30c8\uff08UAT\uff09\u306e\u5b8c\u4e86\u3001SOP\u306e\u9075\u5b88\u306b\u8cac\u4efb\u3092\u8ca0\u3044\u3001\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u3092Idorsia\u793e\u306b\u623b\u3057\u307e\u3059\u3002\u3057\u304b\u3057\u30014\u793e\u306eCRO\u30d1\u30fc\u30c8\u30ca\u30fc\u3092\u76f8\u624b\u306b5\u7a2e\u985e\u306eEDC\u30b7\u30b9\u30c6\u30e0\u3092\u4f7f\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u76e3\u8996\u304c\u56f0\u96e3\u306a\u30ec\u30d9\u30eb\u307e\u3067\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u30e2\u30c7\u30eb\u304c\u5206\u65ad\u5316\u3055\u308c\u3066\u3044\u308b\u3053\u3068\u304c\u6b21\u7b2c\u306b\u308f\u304b\u3063\u3066\u304d\u307e\u3057\u305f\u3002\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u304a\u3088\u3073\u30d7\u30ed\u30b0\u30e9\u30df\u30f3\u30b0\u62c5\u5f53\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u306eVincent Rolland\u6c0f\u306f\u3001\u5f53\u6642\u306e\u3053\u3068\u3092\u6b21\u306e\u3088\u3046\u306b\u632f\u308a\u8fd4\u3063\u3066\u3044\u307e\u3059\u3002\u300c\u5f53\u793e\u306e\u6a19\u6e96eCRF\uff08\u96fb\u5b50\u75c7\u4f8b\u5831\u544a\u66f8\uff09\u306f\u3001CRO\u3084EDC\u30b7\u30b9\u30c6\u30e0\u3054\u3068\u306b\u8abf\u6574\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3057\u305f\u3002\u305d\u306e\u305f\u3081\u3001\u304b\u306a\u308a\u306e\u983b\u5ea6\u3067\u300e\u8eca\u8f2a\u306e\u518d\u767a\u660e\u300f\u3092\u5f37\u3044\u3089\u308c\u3066\u3044\u307e\u3057\u305f\u3002\u300d<\/p>\n<blockquote style=\"padding-bottom: 30px;\"><p>\n<strong>\u300c\u3053\u306e\u65b0\u3057\u3044\u30e2\u30c7\u30eb\u306b\u3088\u308a\u3001\u6a19\u6e96\u5316\u3068\u30c7\u30fc\u30bf\u7ba1\u7406\u306e\u30e1\u30ea\u30c3\u30c8\u304c\u4f59\u3059\u3068\u3053\u308d\u306a\u304f\u5f97\u3089\u308c\u3001\u793e\u5185SOP\u3092\u4f7f\u3063\u3066\u5f53\u793e\u30d7\u30ed\u30bb\u30b9\u306b\u3064\u3044\u3066CRO\u30d1\u30fc\u30c8\u30ca\u30fc\u3092\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u3067\u304d\u307e\u3059\u3002\u300d<\/strong><\/p>\n<p><cite>Idorsia Pharmaceuticals\u793e\u3001\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u304a\u3088\u3073\u30d7\u30ed\u30b0\u30e9\u30df\u30f3\u30b0\u62c5\u5f53\u30c7\u30a3\u30ec\u30af\u30bf\u30fc<br \/>\nVincent Rolland\u6c0f<\/cite>\n<\/p><\/blockquote>\n<p>\u305d\u3053\u3067\u3001Idorsia\u793e\u306fEDC\u69cb\u7bc9\u306e\u5185\u88fd\u5316\u3092\u9078\u629e\u3057\u3001\u30b9\u30bf\u30c7\u30a3\u30c7\u30b6\u30a4\u30f3\u3092Veeva Vault CDMS\u3067\u76f4\u63a5\u884c\u3048\u308b\u3088\u3046\u306b\u3059\u308b\u3053\u3068\u306b\u3057\u307e\u3057\u305f\u3002\u3059\u3079\u3066\u306e\u30b9\u30bf\u30c7\u30a3\u3067\u540c\u3058\u30c4\u30fc\u30eb\u3092\u4f7f\u7528\u3059\u308b\u3053\u3068\u3067\u52b9\u7387\u304c\u9ad8\u307e\u308a\u3001UAT\u30d7\u30ed\u30bb\u30b9\u306e\u8fc5\u901f\u5316\u3001\u30c9\u30ad\u30e5\u30e1\u30f3\u30c8\u751f\u6210\u6642\u306e\u81ea\u52d5\u5316\u306e\u62e1\u5927\u3001\u30a8\u30c7\u30a3\u30c3\u30c8\u30c1\u30a7\u30c3\u30af\u306e\u524a\u6e1b\u3092\u901a\u3058\u3066\u6642\u9593\u304c\u7bc0\u7d04\u3055\u308c\u307e\u3057\u305f\u3002\u300c\u3053\u306e\u65b0\u3057\u3044\u30e2\u30c7\u30eb\u306b\u3088\u308a\u3001\u6a19\u6e96\u5316\u3068\u30c7\u30fc\u30bf\u7ba1\u7406\u306e\u30e1\u30ea\u30c3\u30c8\u304c\u4f59\u3059\u3068\u3053\u308d\u306a\u304f\u5f97\u3089\u308c\u3001\u793e\u5185SOP\u3092\u4f7f\u3063\u3066\u5f53\u793e\u30d7\u30ed\u30bb\u30b9\u306b\u3064\u3044\u3066CRO\u30d1\u30fc\u30c8\u30ca\u30fc\u3092\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u3067\u304d\u307e\u3059\u300d\u3068Rolland\u6c0f\u306f\u4ed8\u3051\u52a0\u3048\u307e\u3059\u3002<\/p>\n<p>Idorsia\u793e\u3068\u306f\u7570\u306a\u308b\u9053\u7b4b\u3092\u305f\u3069\u3063\u3066\u3001\u6a19\u6e96\u5316\u3092\u901a\u3058\u3066\u30c7\u30fc\u30bf\u7ba1\u7406\u3092\u5f37\u5316\u3057\u305f\u30b9\u30dd\u30f3\u30b5\u30fc\u3082\u3042\u308a\u307e\u3059\u3002\u3042\u308b\u4e2d\u5805\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\uff08\u672c\u793e\uff1a\u30e8\u30fc\u30ed\u30c3\u30d1\uff09\u306f\u3001\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u591a\u304f\u306e\u5074\u9762\u3092\u542b\u3081\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u5927\u90e8\u5206\u3092\u5916\u90e8\u59d4\u8a17\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306f\u3001Vault EDC\u3092\u5c0e\u5165\u3059\u308b\u3068\u540c\u6642\u306b\u3001\u69cb\u7bc9\u306e\u5185\u88fd\u5316\u3001\u4e00\u90e8\u5916\u90e8\u59d4\u8a17\u3001\u304a\u3088\u3073\u5b8c\u5168\u5916\u90e8\u59d4\u8a17\u306e\u30b9\u30bf\u30c7\u30a3\u74b0\u5883\u306b\u67d4\u8edf\u306b\u5bfe\u5fdc\u3067\u304d\u308beCRF\u6a19\u6e96\u3092\u69cb\u7bc9\u3057\u307e\u3057\u305f\u3002\u7279\u306bCRO\u3092\u4f7f\u7528\u3059\u308b\u5834\u5408\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u30e9\u30a4\u30d6\u30e9\u30ea\u30fc\u3092\u65e9\u671f\u306b\u69cb\u7bc9\u3059\u308b\u3068\u6642\u9593\u3092\u7bc0\u7d04\u3067\u304d\u308b\u3053\u3068\u304c\u308f\u304b\u308a\u307e\u3057\u305f\u3002<\/p>\n<div style=\"text-align: center;\"><img decoding=\"async\" style=\"margin: 1em auto; width: 100%; max-width: 700px; height: auto;\" src=\"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/03\/article-fig2.jpg\" alt=\"\"><\/div>\n<h3>\u30b9\u30dd\u30f3\u30b5\u30fc\u3068CRO\u306b\u3068\u3063\u3066\u306e\u7d99\u7d9a\u7684\u306a\u30e1\u30ea\u30c3\u30c8<\/h3>\n<p>\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u6d3b\u52d5\u306e\u5927\u90e8\u5206\u3092\u5916\u90e8\u59d4\u8a17\u3059\u308b\u30b9\u30dd\u30f3\u30b5\u30fc\u306f\u3001\u30d1\u30fc\u30c8\u30ca\u30fc\u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u9078\u629e\u306e\u6700\u7d42\u53d7\u76ca\u8005\uff08\u307e\u305f\u306f\u72a0\u7272\u8005\uff09\u3067\u3059\u3002CRO\u304c\u624b\u4f5c\u696d\u4e3b\u4f53\u306e\u30ec\u30ac\u30b7\u30fc\u30b7\u30b9\u30c6\u30e0\u306b\u983c\u3063\u3066\u3044\u308b\u5834\u5408\u3001\u7d50\u679c\u3068\u3057\u3066\u4e0a\u5e02\u306e\u9045\u308c\u3084\u30b3\u30b9\u30c8\u306e\u5897\u52a0\u3092\u62db\u304d\u307e\u3059\u3002\u9006\u306b\u3001CRO\u306b\u4f7f\u7528\u3055\u305b\u305f\u3044EDC\u30b7\u30b9\u30c6\u30e0\u3092\u30b9\u30dd\u30f3\u30b5\u30fc\u304c\u898f\u5b9a\u3059\u308b\u5834\u5408\u3001\u53cc\u65b9\u306b\u30e1\u30ea\u30c3\u30c8\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<blockquote style=\"padding-bottom: 30px;\"><p>\n<strong>\u300c\u5834\u5408\u306b\u3088\u3063\u3066\u306f\u3001EDC\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306e\u69cb\u7bc9\u6642\u9593\u3092\u6700\u592750\uff05\u77ed\u7e2e\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u2026\u3055\u3089\u306b\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u5074\u3067\u308230\uff05\u306e\u30b3\u30b9\u30c8\u524a\u6e1b\u304c\u8a8d\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u300d<\/strong><\/p>\n<p><cite>Syneos Health\u793e\u3001\u81e8\u5e8a\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc<br \/>\nTrevor Griffiths\u6c0f<\/cite>\n<\/p><\/blockquote>\n<p>CRO\u306eSyneos Health\u793e\u306f\u3001\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3092\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u306e\u305f\u3081\u306b\u5b9f\u65bd\u3059\u308b\u81e8\u5e8a\u8a66\u9a13\u306e\u91cd\u8981\u306a\u52a0\u901f\u8981\u56e0\u3068\u898b\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306f\u3001\u6700\u65b0\u306eEDC\u30b7\u30b9\u30c6\u30e0\u304c\u30c7\u30fc\u30bf\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u306e\u65e5\u5e38\u696d\u52d9\u306b\u3082\u305f\u3089\u3059\u5909\u5316\u3092\u76f4\u63a5\u7d4c\u9a13\u3057\u3066\u3044\u307e\u3059\u3002\u30ab\u30b9\u30bf\u30e0\u30d5\u30a1\u30f3\u30af\u30b7\u30e7\u30f3\u304b\u3089\u79fb\u884c\u3059\u308b\uff08\u305d\u3057\u3066\u305d\u306e\u4ee3\u308f\u308a\u306bVault EDC\u5185\u3067\u52d5\u7684\u30eb\u30fc\u30eb\u3068\u30c1\u30a7\u30c3\u30af\u3092\u8a2d\u5b9a\u3059\u308b\uff09\u3053\u3068\u3067\u3001<a href=\"https:\/\/www.veeva.com\/customer-stories\/customer-stories-accelerating-study-builds-with-veeva-vault-edc\/\" rel=\"noopener nofollow\" target=\"_blank\">\u30b9\u30bf\u30c7\u30a3\u69cb\u7bc9\u671f\u9593\u3092\u5927\u5e45\u306b\u77ed\u7e2e<\/a>\u3057\u307e\u3057\u305f\u3002\u540c\u793e\u81e8\u5e8a\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u306eTrevor Griffiths\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u5834\u5408\u306b\u3088\u3063\u3066\u306f\u3001EDC\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u306e\u69cb\u7bc9\u6642\u9593\u3092\u6700\u592750\uff05\u77ed\u7e2e\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u2026\u3055\u3089\u306b\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u5074\u3067\u308230\uff05\u306e\u30b3\u30b9\u30c8\u524a\u6e1b\u304c\u8a8d\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n<blockquote style=\"padding-bottom: 30px;\"><p>\n<strong>\u300c\u305d\u3046\u3057\u305f\u52b9\u7387\u5411\u4e0a\u3092\u5b9f\u73fe\u3067\u304d\u305f\u306e\u306f\u3001\u30b7\u30b9\u30c6\u30e0\u8a2d\u8a08\u306b\u3088\u3063\u3066\u54c1\u8cea\u306b\u96c6\u4e2d\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u3063\u305f\u304b\u3089\u3067\u3059\u3002\u300d<\/strong><\/p>\n<p><cite>Fortrea\u793e\u3001\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8<br \/>\nJerry Yarem\u6c0f<\/cite>\n<\/p><\/blockquote>\n<p>\u30b0\u30ed\u30fc\u30d0\u30ebCRO\u306eFortrea\u793e\u3082\u540c\u69d8\u306b\u3001\u9867\u5ba2\u30b5\u30fc\u30d3\u30b9\u3068\u7af6\u4e89\u529b\u306e\u5411\u4e0a\u3092\u671b\u3093\u3067\u3044\u307e\u3057\u305f\u3002\u305d\u3053\u3067\u3001EDC\u3068RTSM\u304b\u3089\u81e8\u5e8a\u8a66\u9a13\u7ba1\u7406\u30b7\u30b9\u30c6\u30e0\uff08CTMS\uff09\u3068\u96fb\u5b50\u6cbb\u9a13\u30de\u30b9\u30bf\u30fc\u30d5\u30a1\u30a4\u30eb\uff08eTMF\uff09\u306b\u3001\u81e8\u5e8a\u30a4\u30f3\u30d5\u30e9\u3092\u7d71\u5408\u3059\u308b\u3053\u3068\u306b\u3057\u307e\u3057\u305f\u3002\u6700\u65b0\u306eEDC\u3092\u63a1\u7528\u3059\u308b\u3053\u3068\u3067\u3001\u540c\u793e\u306f\u30d7\u30ed\u30b0\u30e9\u30df\u30f3\u30b0\u3068\u624b\u4f5c\u696d\u306b\u304b\u304b\u308b\u6642\u9593\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u3068\u540c\u6642\u306b\u3001\u72ec\u81ea\u30d5\u30a9\u30fc\u30e0\u306e\u4f7f\u7528\u309220\u301c30\uff05\u524a\u6e1b\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u3002Fortrea\u793e\u306e\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u306eJerry Yarem\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u305d\u3046\u3057\u305f\u52b9\u7387\u5411\u4e0a\u3092\u5b9f\u73fe\u3067\u304d\u305f\u306e\u306f\u3001\u30b7\u30b9\u30c6\u30e0\u8a2d\u8a08\u306e\u304a\u304b\u3052\u3067\u54c1\u8cea\u306b\u96c6\u4e2d\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u3063\u305f\u304b\u3089\u3067\u3059\u3002\u300d<\/p>\n<p>CRO\u306eBioforum\u793e\u3082\u307e\u305f\u3001\u5148\u9032\u7684\u3067\u4f7f\u3044\u3084\u3059\u3044\u69cb\u7bc9\u30c4\u30fc\u30eb\u3092\u5099\u3048\u305fEDC\u306b\u30a2\u30c3\u30d7\u30b0\u30ec\u30fc\u30c9\u3059\u308b\u3053\u3068\u3067\u3001\u9867\u5ba2\u306e\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u77ed\u7e2e\u3068\u30b3\u30b9\u30c8\u524a\u6e1b\u3092\u5b9f\u73fe\u3057\u307e\u3057\u305f\u3002\u540c\u793e\u306e\u30c1\u30fc\u30d5\u30c7\u30fc\u30bf\u30b9\u30c8\u30e9\u30c6\u30b8\u30b9\u30c8\u517c\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u30aa\u30d5\u30a3\u30b5\u30fc\u306eTanya du Plessis\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVault EDC\u306f\u3088\u308a\u30a2\u30b8\u30e3\u30a4\u30eb\u3067\u3042\u308a\u3001\u5927\u5e45\u306a\u8fc5\u901f\u5316\u3092\u5b9f\u73fe\u3059\u308b\u74b0\u5883\u3092\u63d0\u4f9b\u3057\u3066\u304f\u308c\u307e\u3059\u3002\u30b9\u30bf\u30c7\u30a3\u30c7\u30b6\u30a4\u30f3\u304c\u8907\u96d1\u3060\u304b\u3089\u3068\u3044\u3063\u3066\u3001\u8907\u96d1\u306a\u69cb\u7bc9\u304c\u5fc5\u8981\u3060\u3068\u306f\u9650\u308a\u307e\u305b\u3093\u3002\u5f93\u6765\u306e\u30ab\u30b9\u30bf\u30e0\u30d5\u30a1\u30f3\u30af\u30b7\u30e7\u30f3\u3067\u306f\u3001\u69cb\u7bc9\u3060\u3051\u3067\u306a\u304f\u691c\u8a3c\u3084\u4fee\u6b63\u306e\u305f\u3081\u306b\u591a\u304f\u306e\u9045\u5ef6\u304c\u767a\u751f\u3057\u307e\u3059\u3002\u30ab\u30b9\u30bf\u30e0\u30d5\u30a1\u30f3\u30af\u30b7\u30e7\u30f3\u3092\u6392\u9664\u3057\u3001\u30eb\u30fc\u30eb\u3092\u4f7f\u7528\u3059\u308b\u3053\u3068\u306f\u30b2\u30fc\u30e0\u30c1\u30a7\u30f3\u30b8\u30e3\u30fc\u3068\u306a\u308a\u307e\u3059\u3002\u8907\u96d1\u306a\u30b9\u30bf\u30c7\u30a3\u30c7\u30b6\u30a4\u30f3\u3067\u3082\u69cb\u7bc9\u304c\u5bb9\u6613\u3067\u3059\u3002\u300d<br \/>\n\u6700\u65b0\u306e\u30b7\u30b9\u30c6\u30e0\u30a2\u30fc\u30ad\u30c6\u30af\u30c1\u30e3\u306f\u3001CRO\u3068\u9867\u5ba2\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u652f\u63f4\u3057\u307e\u3059\u3002\u540c\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u30b9\u30dd\u30f3\u30b5\u30fc\u304cPDF\u3084\u30d7\u30ea\u30f3\u30c8\u30a2\u30a6\u30c8\u3067\u306f\u306a\u304f\u3001\u30b7\u30b9\u30c6\u30e0\u3067\u76f4\u63a5\u30ec\u30d3\u30e5\u30fc\u3067\u304d\u308b\u3053\u3068\u306f\u975e\u5e38\u306b\u52b9\u679c\u7684\u3067\u3059\u3002\u30b9\u30dd\u30f3\u30b5\u30fc\u304c\u5909\u66f4\u3092\u5e0c\u671b\u3059\u308b\u5834\u5408\u3001\u305d\u306e\u4ed5\u7d44\u307f\u3092\u5373\u5ea7\u306b\u793a\u3059\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u305d\u306e\u305f\u3081\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u304c\u5bb9\u6613\u306b\u306a\u308a\u3001\u6700\u521d\u304b\u3089\u6b63\u3057\u304f\u7406\u89e3\u3059\u308b\u306e\u306b\u5f79\u7acb\u3063\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n<blockquote style=\"padding-bottom: 30px;\"><p>\n<strong>\u300cVault EDC\u306e\u30b9\u30d4\u30fc\u30c9\u3068\u67d4\u8edf\u6027\u306f\u3001\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u306e\u77ed\u7e2e\u306b\u975e\u5e38\u306b\u6709\u5229\u3067\u3059\u3002Veeva\u3092\u4f7f\u7528\u3059\u308b\u3068\u3001\u4fee\u6b63\u304c\u4ed6\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u6bd4\u3079\u306670\uff05\u8fc5\u901f\u5316\u3055\u308c\u307e\u3059\u3002\u300d<\/strong><\/p>\n<p><cite>Bioforum\u793e\u3001\u30c1\u30fc\u30d5\u30c7\u30fc\u30bf\u30b9\u30c8\u30e9\u30c6\u30b8\u30b9\u30c8\u517c\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u30aa\u30d5\u30a3\u30b5\u30fc<br \/>\nTanya du Plessis\u6c0f<\/cite>\n<\/p><\/blockquote>\n<p>\u3053\u308c\u3089\u306e\u30e1\u30ea\u30c3\u30c8\u306f\u3001\u7acb\u3061\u4e0a\u3052\u6642\u3060\u3051\u3067\u306a\u304f\u30b9\u30bf\u30c7\u30a3\u671f\u9593\u4e2d\u3082\u305a\u3063\u3068\u7d9a\u304d\u307e\u3059\u3002\u540c\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVault EDC\u306e\u30b9\u30d4\u30fc\u30c9\u3068\u67d4\u8edf\u6027\u306f\u3001\u30bf\u30a4\u30e0\u30e9\u30a4\u30f3\u3092\u9054\u6210\u3059\u308b\u4e0a\u3067\u975e\u5e38\u306b\u6709\u5229\u3067\u3059\u3002Veeva\u3092\u4f7f\u7528\u3059\u308b\u3068\u3001\u4fee\u6b63\u304c\u4ed6\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u6bd4\u3079\u306670\uff05\u8fc5\u901f\u5316\u3055\u308c\u307e\u3059\u3002\u300d<\/p>\n<h3>\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u306e\u9650\u754c<\/h3>\n<p>\u30ec\u30ac\u30b7\u30fc\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u304b\u3089\u8131\u5374\u3057\u3001\u6700\u65b0\u306e\u6a19\u6e96\u5316\u3055\u308c\u305f\u30b7\u30b9\u30c6\u30e0\u3092\u5c0e\u5165\u3059\u308b\u3053\u3068\u306b\u306f\u5927\u304d\u306a\u30e1\u30ea\u30c3\u30c8\u304c\u3042\u308a\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u3068CRO\u306f\u3055\u307e\u3056\u307e\u306a\u30b9\u30bf\u30c7\u30a3\u74b0\u5883\u3067\u305d\u306e\u30e1\u30ea\u30c3\u30c8\u3092\u4eab\u53d7\u3057\u3066\u3044\u307e\u3059\u3002CRF\u304c\u6a19\u6e96\u3068\u30d7\u30ed\u30c8\u30b3\u30eb\u304b\u3089\u76f4\u63a5\u69cb\u7bc9\u3055\u308c\u308b\u305f\u3081\u3001\u304b\u3064\u3066\u306f\u6570\u30ab\u6708\u8981\u3057\u3066\u3044\u305f\u30b9\u30bf\u30c7\u30a3\u69cb\u7bc9\u304c\u4e00\u8cab\u3057\u3066\u8fc5\u901f\u304b\u3064\u52b9\u7387\u7684\u306b\u306a\u308a\u307e\u3059\u3002\u79fb\u884c\u3084\u30c0\u30a6\u30f3\u30bf\u30a4\u30e0\u3092\u4f34\u308f\u306a\u3044\u4fee\u6b63\u306f\u3001\u73fe\u4ee3\u306e\u30b9\u30bf\u30c7\u30a3\u306b\u304a\u3051\u308b\u9577\u5e74\u306e\u554f\u984c\u70b9\u306b\u5bfe\u51e6\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<blockquote style=\"padding-bottom: 30px;\"><p>\n<strong>\u300c\u5b9f\u969b\u3001\u521d\u3081\u3066\u3067\u3082\u3068\u3066\u3082\u697d\u3057\u304f\u5bb9\u6613\u306b\u30d5\u30a9\u30fc\u30e0\u3084\u30eb\u30fc\u30eb\u3092\u30c7\u30b6\u30a4\u30f3\u3067\u304d\u307e\u3059\u3002\u30eb\u30fc\u30eb\u304c\u30d5\u30a9\u30fc\u30e0\u30c7\u30b6\u30a4\u30f3\u306b\u7d44\u307f\u8fbc\u307e\u308c\u3066\u3044\u308b\u305f\u3081\u3001\u30a8\u30c7\u30a3\u30c3\u30c8\u30c1\u30a7\u30c3\u30af\u3092\u5927\u5e45\u306b\u524a\u6e1b\u3067\u304d\u307e\u3059\u3002\u3057\u304b\u3082\u79fb\u884c\u4f5c\u696d\u4e0d\u8981\u3067\u3059\u3002\u3053\u308c\u306f\u3042\u308a\u304c\u305f\u3044\u306e\u4e00\u8a00\u306b\u5c3d\u304d\u307e\u3059\u3002\u300d<\/strong><\/p>\n<p><cite>\u4e2d\u5805\u30b9\u30dd\u30f3\u30b5\u30fc\u306e\u30d7\u30ea\u30f3\u30b7\u30d1\u30eb\u30c7\u30fc\u30bf\u30de\u30cd\u30fc\u30b8\u30e3\u30fc<\/cite>\n<\/p><\/blockquote>\n<p>\u6b27\u5dde\u306e\u4e2d\u5805\u30b9\u30dd\u30f3\u30b5\u30fc\u306e\u30d7\u30ea\u30f3\u30b7\u30d1\u30eb\u30c7\u30fc\u30bf\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u5b9f\u969b\u3001\u521d\u3081\u3066\u3067\u3082\u3068\u3066\u3082\u697d\u3057\u304f\u5bb9\u6613\u306b\u30d5\u30a9\u30fc\u30e0\u3084\u30eb\u30fc\u30eb\u3092\u30c7\u30b6\u30a4\u30f3\u3067\u304d\u307e\u3059\u3002\u30eb\u30fc\u30eb\u304c\u30d5\u30a9\u30fc\u30e0\u30c7\u30b6\u30a4\u30f3\u306b\u7d44\u307f\u8fbc\u307e\u308c\u3066\u3044\u308b\u305f\u3081\u3001\u30a8\u30c7\u30a3\u30c3\u30c8\u30c1\u30a7\u30c3\u30af\u3092\u5927\u5e45\u306b\u524a\u6e1b\u3067\u304d\u307e\u3059\u3002\u3057\u304b\u3082\u79fb\u884c\u4f5c\u696d\u4e0d\u8981\u3067\u3059\u3002\u3053\u308c\u306f\u3042\u308a\u304c\u305f\u3044\u306e\u4e00\u8a00\u306b\u5c3d\u304d\u307e\u3059\u3002\u300d<\/p>\n<p>\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304c <a href=\"https:\/\/www.veeva.com\/products\/veeva-edc\/customers\/\" rel=\"noopener nofollow\" target=\"_blank\">Vault EDC\u306b\u5207\u308a\u66ff\u3048\u3066\u30b9\u30bf\u30c7\u30a3\u306e\u8fc5\u901f\u5316\u3068\u52b9\u7387\u5316\u3092\u5b9f\u73fe\u3057\u305f\u7406\u7531<\/a> \u3092\u304a\u78ba\u304b\u3081\u304f\u3060\u3055\u3044\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u591a\u304f\u306e\u30e6\u30fc\u30b6\u30fc\u304c\u30ec\u30ac\u30b7\u30fc\u30d9\u30f3\u30c0\u30fc\u306b\u3088\u308b\u79fb\u884c\u307e\u305f\u306f\u30a2\u30c3\u30d7\u30b0\u30ec\u30fc\u30c9\u306e\u5fc5\u8981\u306b\u8feb\u3089\u308c\u308b\u4e2d\u3001\u6700\u65b0\u306e\u30a2\u30b8\u30e3\u30a4\u30ebEDC\u30b7\u30b9\u30c6\u30e0\u306b\u5207\u308a\u66ff\u3048\u308b\u6642\u671f\u304c\u6765\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"featured_media":50919,"parent":0,"template":"","class_list":["post-50917","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-area-clinical","resource-type-articles","resource-product-edc"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.1 - aioseo.com -->\n\t<meta name=\"robots\" content=\"max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"ja_JP\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Veeva Japan\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u304b\u3089\u306e\u8131\u5374\uff1a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304a\u3088\u3073 CRO 5 \u793e\u306b\u304a\u3051\u308b\u6700\u65b0 EDC \u306e\u6d3b\u7528\u4e8b\u4f8b | Veeva Japan\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/03\/CDMS-Article-Resource-tile.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/03\/CDMS-Article-Resource-tile.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"340\" \/>\n\t\t<meta property=\"og:image:height\" content=\"240\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-04-15T07:49:58+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-04-15T08:00:41+00:00\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp#listItem\",\"position\":1,\"name\":\"\\u30db\\u30fc\\u30e0\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/jp\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/#listItem\",\"name\":\"\\u30ea\\u30bd\\u30fc\\u30b9\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/#listItem\",\"position\":2,\"name\":\"\\u30ea\\u30bd\\u30fc\\u30b9\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resource-area\\\/clinical\\\/#listItem\",\"name\":\"Clinical\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp#listItem\",\"name\":\"\\u30db\\u30fc\\u30e0\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resource-area\\\/clinical\\\/#listItem\",\"position\":3,\"name\":\"Clinical\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resource-area\\\/clinical\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\\\/#listItem\",\"name\":\"\\u30ec\\u30ac\\u30b7\\u30fc\\u30c4\\u30fc\\u30eb\\u304b\\u3089\\u306e\\u8131\\u5374\\uff1a\\u30d0\\u30a4\\u30aa\\u533b\\u85ac\\u54c1\\u4f01\\u696d\\u304a\\u3088\\u3073 CRO 5 \\u793e\\u306b\\u304a\\u3051\\u308b\\u6700\\u65b0 EDC \\u306e\\u6d3b\\u7528\\u4e8b\\u4f8b\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/#listItem\",\"name\":\"\\u30ea\\u30bd\\u30fc\\u30b9\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\\\/#listItem\",\"position\":4,\"name\":\"\\u30ec\\u30ac\\u30b7\\u30fc\\u30c4\\u30fc\\u30eb\\u304b\\u3089\\u306e\\u8131\\u5374\\uff1a\\u30d0\\u30a4\\u30aa\\u533b\\u85ac\\u54c1\\u4f01\\u696d\\u304a\\u3088\\u3073 CRO 5 \\u793e\\u306b\\u304a\\u3051\\u308b\\u6700\\u65b0 EDC \\u306e\\u6d3b\\u7528\\u4e8b\\u4f8b\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resource-area\\\/clinical\\\/#listItem\",\"name\":\"Clinical\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#organization\",\"name\":\"Veeva Systems Japan\",\"description\":\"The Industry Cloud for Life Sciences\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/veeva-japan\\\/\"]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\\\/#webpage\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\\\/\",\"name\":\"\\u30ec\\u30ac\\u30b7\\u30fc\\u30c4\\u30fc\\u30eb\\u304b\\u3089\\u306e\\u8131\\u5374\\uff1a\\u30d0\\u30a4\\u30aa\\u533b\\u85ac\\u54c1\\u4f01\\u696d\\u304a\\u3088\\u3073 CRO 5 \\u793e\\u306b\\u304a\\u3051\\u308b\\u6700\\u65b0 EDC \\u306e\\u6d3b\\u7528\\u4e8b\\u4f8b | Veeva Japan\",\"inLanguage\":\"ja\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\\\/#breadcrumblist\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/CDMS-Article-Resource-tile.png\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\\\/#mainImage\",\"width\":340,\"height\":240,\"caption\":\"CDMS Article Resource tile\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/resources\\\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\\\/#mainImage\"},\"datePublished\":\"2025-04-15T16:49:58+09:00\",\"dateModified\":\"2025-04-15T17:00:41+09:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#website\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/\",\"name\":\"Veeva Japan\",\"description\":\"The Industry Cloud for Life Sciences\",\"inLanguage\":\"ja\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u304b\u3089\u306e\u8131\u5374\uff1a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304a\u3088\u3073 CRO 5 \u793e\u306b\u304a\u3051\u308b\u6700\u65b0 EDC \u306e\u6d3b\u7528\u4e8b\u4f8b | Veeva Japan<\/title>\n\n","aioseo_head_json":{"title":"\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u304b\u3089\u306e\u8131\u5374\uff1a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304a\u3088\u3073 CRO 5 \u793e\u306b\u304a\u3051\u308b\u6700\u65b0 EDC \u306e\u6d3b\u7528\u4e8b\u4f8b | Veeva Japan","description":"","canonical_url":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/","robots":"max-snippet:-1, max-image-preview:large, max-video-preview:-1","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp#listItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/www.veeva.com\/jp","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resources\/#listItem","name":"\u30ea\u30bd\u30fc\u30b9"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resources\/#listItem","position":2,"name":"\u30ea\u30bd\u30fc\u30b9","item":"https:\/\/www.veeva.com\/jp\/resources\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resource-area\/clinical\/#listItem","name":"Clinical"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp#listItem","name":"\u30db\u30fc\u30e0"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resource-area\/clinical\/#listItem","position":3,"name":"Clinical","item":"https:\/\/www.veeva.com\/jp\/resource-area\/clinical\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/#listItem","name":"\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u304b\u3089\u306e\u8131\u5374\uff1a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304a\u3088\u3073 CRO 5 \u793e\u306b\u304a\u3051\u308b\u6700\u65b0 EDC \u306e\u6d3b\u7528\u4e8b\u4f8b"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resources\/#listItem","name":"\u30ea\u30bd\u30fc\u30b9"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/#listItem","position":4,"name":"\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u304b\u3089\u306e\u8131\u5374\uff1a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304a\u3088\u3073 CRO 5 \u793e\u306b\u304a\u3051\u308b\u6700\u65b0 EDC \u306e\u6d3b\u7528\u4e8b\u4f8b","previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/resource-area\/clinical\/#listItem","name":"Clinical"}}]},{"@type":"Organization","@id":"https:\/\/www.veeva.com\/jp\/#organization","name":"Veeva Systems Japan","description":"The Industry Cloud for Life Sciences","url":"https:\/\/www.veeva.com\/jp\/","sameAs":["https:\/\/www.linkedin.com\/company\/veeva-japan\/"]},{"@type":"WebPage","@id":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/#webpage","url":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/","name":"\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u304b\u3089\u306e\u8131\u5374\uff1a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304a\u3088\u3073 CRO 5 \u793e\u306b\u304a\u3051\u308b\u6700\u65b0 EDC \u306e\u6d3b\u7528\u4e8b\u4f8b | Veeva Japan","inLanguage":"ja","isPartOf":{"@id":"https:\/\/www.veeva.com\/jp\/#website"},"breadcrumb":{"@id":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/#breadcrumblist"},"image":{"@type":"ImageObject","url":"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/03\/CDMS-Article-Resource-tile.png","@id":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/#mainImage","width":340,"height":240,"caption":"CDMS Article Resource tile"},"primaryImageOfPage":{"@id":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/#mainImage"},"datePublished":"2025-04-15T16:49:58+09:00","dateModified":"2025-04-15T17:00:41+09:00"},{"@type":"WebSite","@id":"https:\/\/www.veeva.com\/jp\/#website","url":"https:\/\/www.veeva.com\/jp\/","name":"Veeva Japan","description":"The Industry Cloud for Life Sciences","inLanguage":"ja","publisher":{"@id":"https:\/\/www.veeva.com\/jp\/#organization"}}]},"og:locale":"ja_JP","og:site_name":"Veeva Japan","og:type":"article","og:title":"\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u304b\u3089\u306e\u8131\u5374\uff1a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304a\u3088\u3073 CRO 5 \u793e\u306b\u304a\u3051\u308b\u6700\u65b0 EDC \u306e\u6d3b\u7528\u4e8b\u4f8b | Veeva Japan","og:url":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/","og:image":"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/03\/CDMS-Article-Resource-tile.png","og:image:secure_url":"https:\/\/www.veeva.com\/jp\/wp-content\/uploads\/2025\/03\/CDMS-Article-Resource-tile.png","og:image:width":340,"og:image:height":240,"article:published_time":"2025-04-15T07:49:58+00:00","article:modified_time":"2025-04-15T08:00:41+00:00"},"aioseo_meta_data":{"post_id":"50917","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"open_ai":"{\"title\":{\"suggestions\":[],\"usage\":0},\"description\":{\"suggestions\":[],\"usage\":0}}","created":"2025-03-05 06:11:33","updated":"2026-08-22 17:19:08","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":"2026-08-22 17:19:08"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/jp\" title=\"\u30db\u30fc\u30e0\">\u30db\u30fc\u30e0<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/jp\/resources\/\" title=\"\u30ea\u30bd\u30fc\u30b9\">\u30ea\u30bd\u30fc\u30b9<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/jp\/resource-area\/clinical\/\" title=\"Clinical\">Clinical<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u304b\u3089\u306e\u8131\u5374\uff1a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304a\u3088\u3073 CRO 5 \u793e\u306b\u304a\u3051\u308b\u6700\u65b0 EDC \u306e\u6d3b\u7528\u4e8b\u4f8b\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"\u30db\u30fc\u30e0","link":"https:\/\/www.veeva.com\/jp"},{"label":"\u30ea\u30bd\u30fc\u30b9","link":"https:\/\/www.veeva.com\/jp\/resources\/"},{"label":"Clinical","link":"https:\/\/www.veeva.com\/jp\/resource-area\/clinical\/"},{"label":"\u30ec\u30ac\u30b7\u30fc\u30c4\u30fc\u30eb\u304b\u3089\u306e\u8131\u5374\uff1a\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u304a\u3088\u3073 CRO 5 \u793e\u306b\u304a\u3051\u308b\u6700\u65b0 EDC \u306e\u6d3b\u7528\u4e8b\u4f8b","link":"https:\/\/www.veeva.com\/jp\/resources\/five-biopharmas-and-cros-share-how-they-benefit-from-a-modern-edc-across-trial-settings\/"}],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/resources\/50917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/resources\/50917\/revisions"}],"predecessor-version":[{"id":50920,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/resources\/50917\/revisions\/50920"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media\/50919"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=50917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}